PROPYLENE GLYCOL EMULSION

PROPYLENE GLYCOL EMULSION was reported 148 times

PROPYLENE GLYCOL EMULSION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONTAMINATED PRODUCT ADMINISTERED 6 0.0984
1 PRODUCT CONTAMINATION MICROBIAL 25 0.0210
2 GIANT PAPILLARY CONJUNCTIVITIS 1 0.0200
3 PERIORBITAL PAIN 7 0.0083
4 EYELID PAIN 12 0.0059
5 EYELASH CHANGES 1 0.0056
6 EXPOSURE TO FUNGUS 1 0.0047
7 PRODUCT WITH QUALITY ISSUE ADMINISTERED 2 0.0045
8 HYPOAESTHESIA EYE 2 0.0034
9 EYE INFECTION VIRAL 1 0.0031
10 PERIORBITAL IRRITATION 1 0.0029
11 SUPERFICIAL INJURY OF EYE 3 0.0027
12 BONE TUBERCULOSIS 1 0.0026
13 EYE ALLERGY 3 0.0019
14 PRODUCT CLOSURE ISSUE 1 0.0018
15 GLASSY EYES 1 0.0014
16 PRODUCT DESIGN ISSUE 1 0.0014
17 OCULAR DISCOMFORT 15 0.0013
18 FEAR OF FALLING 1 0.0012
19 VITAL FUNCTIONS ABNORMAL 1 0.0012
20 FOREIGN BODY SENSATION IN EYES 7 0.0011
21 EYE PAIN 61 0.0011
22 EYELID MARGIN CRUSTING 3 0.0010
23 EYELID IRRITATION 2 0.0008
24 PHOTOPHOBIA 13 0.0007
25 PRODUCT DELIVERY MECHANISM ISSUE 3 0.0006
26 ERYTHEMA OF EYELID 3 0.0006
27 METAMORPHOPSIA 1 0.0005
28 AURA 1 0.0005
29 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
30 OCULAR HYPERAEMIA 24 0.0005
31 EYE DISCHARGE 5 0.0005
32 HORDEOLUM 2 0.0005
33 EYE IRRITATION 26 0.0005
34 SINUS OPERATION 1 0.0004
35 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
36 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
37 ASTHENOPIA 2 0.0004
38 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
39 EYE INFECTION 4 0.0004
40 PERIORBITAL SWELLING 2 0.0004
41 PRODUCT CONTAINER ISSUE 3 0.0003
42 VASCULAR GRAFT 1 0.0003
43 DEVICE USE ISSUE 6 0.0003
44 EYE SWELLING 12 0.0003
45 EYELIDS PRURITUS 1 0.0003
46 CONJUNCTIVAL HYPERAEMIA 1 0.0003
47 BLINDNESS TRANSIENT 2 0.0003
48 LACRIMATION INCREASED 8 0.0003
49 PARANASAL SINUS DISCOMFORT 1 0.0003
50 DRY EYE 12 0.0002
51 DIVERTICULUM INTESTINAL 1 0.0002
52 FACIAL PAIN 2 0.0002
53 PRODUCT ADMINISTRATION ERROR 4 0.0002
54 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
55 SKIN ATROPHY 1 0.0002
56 ODYNOPHAGIA 1 0.0002
57 SWELLING OF EYELID 1 0.0002
58 VISION BLURRED 21 0.0002
59 EYE PRURITUS 5 0.0001
60 RETINAL HAEMORRHAGE 1 0.0001
61 HYPERAESTHESIA 1 0.0001
62 VISUAL ACUITY REDUCED 4 0.0001
63 ANAL INCONTINENCE 1 0.0001
64 OPTIC NEURITIS 1 0.0001
65 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
66 RETINAL DETACHMENT 1 0.0001
67 PHARYNGEAL SWELLING 1 0.0001
68 THERAPY CHANGE 1 0.0001
69 JOINT DISLOCATION 1 0.0001
70 ASPIRATION 1 0.0001
71 MADAROSIS 1 0.0001
72 SPINAL OPERATION 1 0.0001
73 INTRAOCULAR PRESSURE INCREASED 1 0.0001
74 DIPLOPIA 2 0.0001
75 INTENTIONAL DOSE OMISSION 2 0.0001
76 THERAPY INTERRUPTED 5 0.0001
77 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
78 PRODUCT USE COMPLAINT 1 0.0001
79 GLAUCOMA 1 0.0001
80 EAR PAIN 1 0.0001
81 HAEMORRHOIDS 1 0.0001
82 MOUTH ULCERATION 1 0.0000
83 INTENTIONAL PRODUCT MISUSE 4 0.0000
84 GLOSSODYNIA 1 0.0000
85 EAR INFECTION 1 0.0000
86 THROAT TIGHTNESS 1 0.0000
87 LIMB INJURY 1 0.0000
88 HAEMOPTYSIS 1 0.0000
89 PAIN IN JAW 1 0.0000
90 HYPERSOMNIA 1 0.0000
91 DYSSTASIA 1 0.0000
92 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
93 VISUAL IMPAIRMENT 4 0.0000
94 RHINORRHOEA 2 0.0000
95 EXPIRED PRODUCT ADMINISTERED 1 0.0000
96 SKIN BURNING SENSATION 2 0.0000
97 ACCIDENTAL OVERDOSE 1 0.0000
98 PRODUCT DOSE OMISSION ISSUE 8 0.0000
99 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
100 BLINDNESS 1 0.0000
101 BALANCE DISORDER 2 0.0000
102 HEADACHE 14 0.0000
103 THROAT IRRITATION 1 0.0000
104 THERAPY NON-RESPONDER 1 0.0000
105 SINUSITIS 2 0.0000
106 ILLNESS 2 0.0000
107 NERVOUSNESS 1 0.0000
108 ANAPHYLACTIC REACTION 1 0.0000
109 CHILLS 2 0.0000
110 NASAL CONGESTION 1 0.0000
111 CATARACT 1 0.0000
112 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
113 VERTIGO 1 0.0000
114 DISCOMFORT 1 0.0000
115 NASOPHARYNGITIS 3 0.0000
116 PRODUCT USE ISSUE 3 0.0000
117 INTENTIONAL OVERDOSE 1 0.0000
118 SWELLING FACE 1 0.0000
119 HYPOTENSION 3 0.0000
120 DYSGEUSIA 1 0.0000
121 INJECTION SITE SWELLING 1 0.0000
122 SKIN EXFOLIATION 1 0.0000
123 PRODUCT STORAGE ERROR 1 0.0000
124 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
125 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
126 OROPHARYNGEAL PAIN 1 0.0000
127 CHEST PAIN 2 0.0000
128 HYPERSENSITIVITY 2 0.0000
129 DYSPHAGIA 1 0.0000
130 MIGRAINE 1 0.0000
131 GAIT DISTURBANCE 2 0.0000
132 ATRIAL FIBRILLATION 1 0.0000
133 SYNCOPE 1 0.0000
134 DRUG INEFFECTIVE 13 0.0000
135 ABDOMINAL DISTENSION 1 0.0000
136 INFLUENZA 1 0.0000
137 SEIZURE 1 0.0000
138 INJECTION SITE ERYTHEMA 1 0.0000
139 HYPERHIDROSIS 1 0.0000
140 DRY SKIN 1 0.0000
141 COUGH 2 0.0000
142 HYPOAESTHESIA 1 0.0000
143 CONDITION AGGRAVATED 2 0.0000
144 URTICARIA 1 0.0000
145 MUSCLE SPASMS 1 0.0000
146 ERYTHEMA 1 0.0000
147 HYPERTENSION 1 0.0000
148 CONSTIPATION 1 0.0000
149 BACK PAIN 1 0.0000
150 FEELING ABNORMAL 1 0.0000
151 DIZZINESS 2 0.0000
152 FATIGUE 3 0.0000
153 DYSPNOEA 2 0.0000
154 PAIN IN EXTREMITY 1 0.0000
155 DIARRHOEA 2 0.0000
156 FALL 1 0.0000
157 PYREXIA 1 0.0000
158 PRURITUS 1 0.0000
159 NAUSEA 2 0.0000
160 VOMITING 1 0.0000
161 OFF LABEL USE 1 0.0000